CASTLE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
CASTLE BIOSCIENCES, INC. (CSTL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 38.24 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 25.66K shares, a 40.22% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 12.59K shares, a 27.26% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 8.37K shares, a 67.19% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 28.27K shares, a 20.22% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 96.87K shares, a 11.71% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 86.72K shares, a 37.84% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 139.51K shares, a 50.49% decline from fiscal 2022.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 281.76K shares, a 34.64% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 25.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | 38.24K shares 10-Q · filed 2026-07-30 | 46.62K shares derived: sum of 3 quarters · filed 2026-07-30 | 74.89K shares derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 12.59K shares 10-Q · filed 2026-05-06 | 20.96K shares derived: sum of 2 quarters · filed 2026-05-06 | 49.24K shares derived: sum of 3 quarters · filed 2026-05-06 | 92.16K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 8.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 36.65K shares derived: sum of 2 quarters · filed 2026-02-26 | 79.56K shares derived: sum of 3 quarters · filed 2026-02-26 | 96.87K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 28.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 71.19K shares derived: sum of 2 quarters · filed 2025-11-03 | 88.50K shares 10-Q · filed 2025-11-03 | 114.02K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | 42.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 60.23K shares 10-Q · filed 2025-08-04 | 85.75K shares derived: sum of 3 quarters · filed 2026-02-26 | 121.19K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | 17.31K shares 10-Q · filed 2025-05-05 | 42.83K shares derived: sum of 2 quarters · filed 2026-02-26 | 78.27K shares derived: sum of 3 quarters · filed 2026-02-26 | 86.25K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | 25.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 60.96K shares derived: sum of 2 quarters · filed 2026-02-26 | 68.94K shares derived: sum of 3 quarters · filed 2026-02-26 | 86.72K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 35.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 43.41K shares derived: sum of 2 quarters · filed 2024-11-04 | 61.20K shares 10-Q · filed 2024-11-04 | 106.88K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 7.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | 25.76K shares 10-Q · filed 2024-08-05 | 71.44K shares derived: sum of 3 quarters · filed 2026-02-26 | 101.59K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 17.78K shares 10-Q · filed 2024-05-02 | 63.47K shares derived: sum of 2 quarters · filed 2026-02-26 | 93.62K shares derived: sum of 3 quarters · filed 2026-02-26 | 118.12K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 45.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 75.84K shares derived: sum of 2 quarters · filed 2026-02-26 | 100.34K shares derived: sum of 3 quarters · filed 2026-02-26 | 139.51K shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 30.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 54.65K shares derived: sum of 2 quarters · filed 2023-11-02 | 93.82K shares 10-Q · filed 2023-11-02 | 137.13K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 24.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 63.67K shares 10-Q · filed 2023-08-02 | 106.98K shares derived: sum of 3 quarters · filed 2025-02-27 | 204.96K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 39.17K shares 10-Q · filed 2023-05-03 | 82.47K shares derived: sum of 2 quarters · filed 2025-02-27 | 180.46K shares derived: sum of 3 quarters · filed 2025-02-27 | 262.78K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 43.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 141.29K shares derived: sum of 2 quarters · filed 2025-02-27 | 223.62K shares derived: sum of 3 quarters · filed 2025-02-27 | 281.76K shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 97.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 180.31K shares derived: sum of 2 quarters · filed 2022-11-02 | 238.45K shares 10-Q · filed 2022-11-02 | 309.84K shares derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | 82.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 140.47K shares 10-Q · filed 2022-08-08 | 211.85K shares derived: sum of 3 quarters · filed 2023-02-28 | 242.90K shares derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | 58.14K shares 10-Q · filed 2022-05-09 | 129.53K shares derived: sum of 2 quarters · filed 2023-02-28 | 160.57K shares derived: sum of 3 quarters · filed 2023-02-28 | 192.82K shares derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | 71.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 102.43K shares derived: sum of 2 quarters · filed 2023-02-28 | 134.68K shares derived: sum of 3 quarters · filed 2023-02-28 | 209.26K shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 31.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 63.29K shares derived: sum of 2 quarters · filed 2021-11-08 | 137.87K shares 10-Q · filed 2021-11-08 | 147.87K shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | 32.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 106.83K shares 10-Q · filed 2021-08-09 | 116.83K shares derived: sum of 3 quarters · filed 2022-02-28 | 176.30K shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | 74.58K shares 10-Q · filed 2021-05-10 | 84.58K shares derived: sum of 2 quarters · filed 2022-02-28 | 144.06K shares derived: sum of 3 quarters · filed 2022-02-28 | 156.71K shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 69.47K shares derived: sum of 2 quarters · filed 2022-02-28 | 82.12K shares derived: sum of 3 quarters · filed 2022-02-28 | 94.32K shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 59.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 72.12K shares derived: sum of 2 quarters · filed 2020-11-09 | 84.32K shares 10-Q · filed 2020-11-09 | 93.81K shares derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | 12.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 24.85K shares 10-Q · filed 2020-08-10 | 34.34K shares derived: sum of 3 quarters · filed 2021-03-11 | |
| 2020-03-31 | 12.20K shares 10-Q · filed 2020-05-11 | 21.69K shares derived: sum of 2 quarters · filed 2021-03-11 | ||
| 2019-12-31 | 9.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 39.83K shares 10-K · filed 2021-03-11 | ||
| 2019-09-30 | 30.34K shares 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | 77.04K shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |